Abstract
Biotechnologies are those technologies living organisms use to keep themselves alive and which, once discovered, human beings use to make products useful to them. Biotechnologies are at the base of the phenomenon of life and so they are naturally present in nature. They are not invented by man, they are instead discovered while studying the phenomenon of life. So biotechnologies differ from techno
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Issaq HJ, Van KN, Waybright TJ et al (2009) Analytical and statistical approaches to metabolomics research. J Sep Sci 32:2183–2199
Wang LN, Zhou Y, Zhu TY et al (2008) Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS. J Proteome Res 7:3597–3601
Wishart DS (2005) Metabolomics: the principles and applications to transplantation. Am J Transplant 5:2814–2820
Henneges C, Bullinger D, Fux R et al (2009) Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection. BMC Cancer 9:104–114
Chan CE, Koh PK, Mal M et al (2009) Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J Proteome Res 8:352–361
Yanga J, Xua G, Zhenga Y et al (2004) Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B Analyt Technol Biomed Life Sci 813:59–65
Claudino WM, Quattrone A, Biganzoli L et al (2007) Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 25:2840–2846
Brindle JT, Antti H, Holmes E et al (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nature Medicine 8:1439–1444
Barba I, de Leon G, Martin E et al (2008) Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 60:27–32
Cesario A, Galetta D, Russo P et al (2003) The role of the surgeon in translational research. Lancet 362:1082
Gittes GK (2006) The surgeon-scientist in a new biomedical research era. Surgery 140:123–131
Buchwald H (1981) The scientist-surgeon. Am J Surg 142:245–246
Mocellin S, Lise M, Nitti D (2005) Targeted therapy for colorectal cancer: mapping the way. Trends Mol Med 11:327–335
Mocellin S, Provenzano M, Rossi CR et al (2005) DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer. Ann Surg 241:16–26
Mocellin S, Rossi CR, Traldi P et al (2004) Molecular oncology in the post-genomic era: the challenge of proteomics. Trends Mol Med 10:24–32
Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a criticai review of the literature. Int J Cancer 112:357–364
Petricoin EF 3rd, Bichsel VE, Calvert VS et al (2005) Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Onco1 23:3614–3621
Nitti D, Belluco C, Mammano E (2002) Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. J Surg Oncol 81:167–175; discussion 175–176
Lise M, Mocellin S, Pilati PL, Nitti D (2005) Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. Front Biosci 10:3042–3057
Wang Y, Jatkoe T, Zhang Y et al (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. J Clin Oncol 22:1564–1571
Resnik MB, Routhier J, Konkin T et al (2004) Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res 10:3069–3075
Mocelli S, Rossi C, Pilati P et al (2003) Quantitative real time PCR: a powerful ally in cancer research. Trends Moi Med 9:189–195
Takeuchi H, Morton DL, Kuo C et al (2004) Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients. J Clin Onco1 22:2671–2680
Zippelius A, Pantel K (2000) RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci 906:110–123
Mariadason JM, Arango D, Shi Q et al (2003) Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 63:8791–8812
Arango D, Wilson AJ, Shi Q et al (2004) Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer 91:1931–1946
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Italia
About this chapter
Cite this chapter
Barbarisi, A. (2011). The Philosophy of Biotechnology. In: Barbarisi, A. (eds) Biotechnology in Surgery. Updates in Surgery, vol 0. Springer, Milano. https://doi.org/10.1007/978-88-470-1658-3_1
Download citation
DOI: https://doi.org/10.1007/978-88-470-1658-3_1
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1657-6
Online ISBN: 978-88-470-1658-3
eBook Packages: MedicineMedicine (R0)